Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin (Q45750536)

15 December 2017

title

Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin (English)

1 reference

15 December 2017

0 references

X Saelens

1 reference

15 December 2017

Walter Fiers

object named as

W Fiers

1 reference

15 December 2017

author name string

P Vanlandschoot

1 reference

15 December 2017

W Martinet

1 reference

15 December 2017

M Maras

1 reference

15 December 2017

S Neirynck

1 reference

15 December 2017

R Contreras

1 reference

15 December 2017

W M Jou

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

15 December 2017

published in

FEBS Journal

1 reference

15 December 2017

volume

260

1 reference

15 December 2017

issue

1 reference

15 December 2017

page(s)

166-175

1 reference

15 December 2017

Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Complete structure of A/duck/Ukraine/63 influenza hemagglutinin gene: animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Variation of influenza A, B, and C viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Molecular mechanisms of variation in influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Evidence for host-cell selection of influenza virus antigenic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Safety considerations for nucleic acid vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Vaccine technologies: view to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Recombinant neuraminidase vaccine protects against lethal influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1 /80 (H7N7) influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Interference with a conformational change in the haemagglutinin molecule of influenza virus by antibodies as a possible neutralization mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Activation of influenza A viruses by trypsin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Protection of Mice Against a Lethal Influenza Challenge by Immunization with Yeast‐Derived Recombinant Influenza Neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

High-level transient expression of influenza virus proteins from a series of SV40 late and early replacement vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Complete structure of the hemagglutinin gene from the human influenza A/Victoria/3/75 (H3N2) strain as determined from cloned DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

The analysis of fluorophore-labeled glycans by high-resolution polyacrylamide gel electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

pH-dependent aggregation and secretion of soluble monomeric influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Size distribution and general structural features of N-linked oligosaccharides from the methylotrophic yeast, Pichia pastoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Foreign gene expression in yeast: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.1999.00150.X

10.1046/J.1432-1327.1999.00150.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017